Data on the effect of initial combination therapy with ambrisentan and tadalafil on long-term outcomes in patients with pulmonary arterial hypertension are scarce.

Galie, N., Barbera, J.A., Frost, A.E., Ghofrani, H., Hoeper, M.M., Mclaughlin, V.V., et al. (2015). Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. NEW ENGLAND JOURNAL OF MEDICINE, 373(9), 834-844 [10.1056/NEJMoa1413687].

Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension

2015

Abstract

Data on the effect of initial combination therapy with ambrisentan and tadalafil on long-term outcomes in patients with pulmonary arterial hypertension are scarce.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
eng
Adult; Aged; Carbolines; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Hypertension, Pulmonary; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phenylpropionates; Pyridazines; Risk Factors; Tadalafil
Galie, N., Barbera, J.A., Frost, A.E., Ghofrani, H., Hoeper, M.M., Mclaughlin, V.V., et al. (2015). Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. NEW ENGLAND JOURNAL OF MEDICINE, 373(9), 834-844 [10.1056/NEJMoa1413687].
Galie, N; Barbera, J; Frost, A; Ghofrani, H; Hoeper, M; Mclaughlin, V; Peacock, A; Simonneau, G; Vachiery, J; Grunig, E; Oudiz, R; Vonk Noordegraaf, A; White, R; Blair, C; Gillies, H; Miller, K; Harris, J; Langley, J; Rubin, L; Ussia, Gp
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/136813
Citazioni
  • ???jsp.display-item.citation.pmc??? 276
  • Scopus 662
  • ???jsp.display-item.citation.isi??? 614
social impact